Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): A phase (ph) II study (DESTINY-Lung02) Meeting Abstract
| Authors: | Smit, E. F. F.; Li, B. T.; Mazieres, J.; Planchard, D.; Nakagawa, K.; Goto, K.; Paz-Ares, L.; Novello, S.; Yang, J. C. H.; Ahn, M. J.; Liu, G.; O'Byrne, K.; Aregay, M.; Shiga, R.; Saxena, K.; Meinhardt, G.; Jänne, P. A. |
| Abstract Title: | Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): A phase (ph) II study (DESTINY-Lung02) |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S1032 |
| End Page: | S1033 |
| Language: | English |
| ACCESSION: | WOS:000700527702374 |
| DOI: | 10.1016/j.annonc.2021.08.1962 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1361TiP -- Source: Wos |
